Comparison Study of Computational Prediction Tools for Drug-Target Binding Affinities
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The drug development is generally arduous, costly, and success rates are low. Thus, the identification of drug-target interactions (DTIs) has become a crucial step in early stages of drug discovery. Consequently, developing computational approaches capable of identifying potential DTIs with minimum error rate are increasingly being pursued. These computational approaches aim to narrow down the search space for novel DTIs and shed light on drug functioning context. Most methods developed to date use binary classification to predict if the interaction between a drug and its target exists or not. However, it is more informative but also more challenging to predict the strength of the binding between a drug and its target. If that strength is not sufficiently strong, such DTI may not be useful. Therefore, the methods developed to predict drug-target binding affinities (DTBA) are of great value. In this study, we provide a comprehensive overview of the existing methods that predict DTBA. We focus on the methods developed using artificial intelligence (AI), machine learning (ML), and deep learning (DL) approaches, as well as related benchmark datasets and databases. Furthermore, guidance and recommendations are provided that cover the gaps and directions of the upcoming work in this research area. To the best of our knowledge, this is the first comprehensive comparison analysis of tools focused on DTBA with reference to AI/ML/DL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On Information and Sufficiency
Kullback, S., & Leibler, R. A. (1951) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177729694 · Cited by 20,193
node2vec: Scalable Feature Learning for Networks
Grover, A., & Leskovec, J. (2016) · Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining · doi:10.1145/2939672.2939754 · Cited by 10,926 · cited 1×
“Also, graph embedding techniques such as DeepWalk (Perozzi et al., 2014), node2vec (Grover and Leskovec, 2016), metapath2vec (Dong et al., 2017; Zhu et al., 2018), or Line (Tang et al., 2015) can be applied to the DTBA graph to obtain useful features for prediction.”
MethodDeepWalk: online learning of social representations
Perozzi, B., Al-Rfou, R., & Skiena, S. (2014) · Proceedings of the 20th ACM SIGKDD international conference on Knowledge discovery and data mining · doi:10.1145/2623330.2623732 · Cited by 10,123 · cited 2×
“Also, graph embedding techniques such as DeepWalk (Perozzi et al., 2014), node2vec (Grover and Leskovec, 2016), metapath2vec (Dong et al.”
MethodChai, T., & Draxler, R. R. (2014) · Geoscientific Model Development · doi:10.5194/gmd-7-1247-2014 · Cited by 8,761
Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436 · cited 1×
“DeepDTA uses SMILES, the one-dimensional representation of the drug chemical structure (Weininger, 1988, 1990), as representation of the drug input data for drugs, while the amino acid sequences are used to represent the input data for proteins.”
MethodChou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178 · cited 2×
“Several drugs act by inhibiting these specific enzymes (Chou and Talalay, 1984; Tang et al., 2017).”
BackgroundLINE: Large-scale Information Network Embedding
Tang, J., Qu, M., Wang, M., Zhang, M., Yan, J., & Mei, Q. (2015) · Proceedings of the 24th International Conference on World Wide Web · doi:10.1145/2736277.2741093 · Cited by 5,416 · cited 3×
“Also, graph embedding techniques such as DeepWalk (Perozzi et al., 2014), node2vec (Grover and Leskovec, 2016), metapath2vec (Dong et al., 2017; Zhu et al., 2018), or Line (Tang et al., 2015) can be applied to the DTBA graph to obtain useful features for prediction.”
BackgroundMethodThe price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
A few useful things to know about machine learning
Domingos, P. (2012) · Communications of the ACM · doi:10.1145/2347736.2347755 · Cited by 3,326 · cited 1×
“Overfitting happens when a model learns many details, including noise from the training data and fits the training data very well but cannot fit the test data well (Domingos, 2012).”
BackgroundA survey of deep neural network architectures and their applications
Liu, W., Wang, Z., Liu, X., Zeng, N., Liu, Y., & Alsaadi, F. E. (2017) · Neurocomputing · doi:10.1016/j.neucom.2016.12.038 · Cited by 3,239 · cited 7×
“Recently and in this big data era, DL approaches have been successfully used to address diverse problems in bioinformatics/cheminformatics applications (Ekins, 2016; Kalkatawi et al., 2019; Li Y. et al., 2019) (Schmidhuber, 2015; Liu et al., 2017).”
BackgroundMethodInfluentialApplications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228
Comprehensive analysis of kinase inhibitor selectivity
Davis, M. I., Hunt, J. P., Herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K., & Zarrinkar, P. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1990 · Cited by 2,409
Similarity network fusion for aggregating data types on a genomic scale
Wang, B., Mezlini, A. M., Demir, F., Fiume, M., Tu, Z., Brudno, M., Haibe-Kains, B., & Goldenberg, A. (2014) · Nature Methods · doi:10.1038/nmeth.2810 · Cited by 2,036
A Comprehensive Survey of Graph Embedding: Problems, Techniques, and Applications
Cai, H., Zheng, V. W., & Chang, K. C.-C. (2018) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2018.2807452 · Cited by 2,034
Graph embedding techniques, applications, and performance: A survey
Goyal, P., & Ferrara, E. (2018) · Knowledge-Based Systems · doi:10.1016/j.knosys.2018.03.022 · Cited by 1,801
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248 · cited 1×
“For example, some studies predicted DTIs by integrating drug side-effects information (Campillos et al., 2008; Mizutani et al., 2012), or drug-diseases interaction (Wang W.”
BackgroundThe PDBbind database: methodologies and updates
Wang, R., Fang, X., Lu, Y., Yang, C.-Y., & Wang, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm048957q · Cited by 933
Discovery of drug mode of action and drug repositioning from transcriptional responses
Iorio, F., Bosotti, R., Scacheri, E., Belcastro, V., Mithbaokar, P., Ferriero, R., Murino, L., Tagliaferri, R., Brunetti-Pierri, N., Isacchi, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000138107 · Cited by 816
Tsubaki, M., Tomii, K., & Sese, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty535 · Cited by 688 · cited 1×
“2018), and ML and DL techniques (Liu Y. et al., 2016; Rayhan et al., 2017; Zong et al., 2017; Tsubaki et al., 2019) to develop prediction models for DTI problem.”
MethodArrowsmith, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3439 · Cited by 622
Exploiting machine learning for end-to-end drug discovery and development
Ekins, S., Puhl, A. C., Zorn, K. M., Lane, T. R., Russo, D. P., Klein, J. J., Hickey, A. J., & Clark, A. M. (2019) · Nature Materials · doi:10.1038/s41563-019-0338-z · Cited by 578
Deep learning in bioinformatics: Introduction, application, and perspective in the big data era
Li, Y., Huang, C., Ding, L., Li, Z., Pan, Y., & Gao, X. (2019) · Methods · doi:10.1016/j.ymeth.2019.04.008 · Cited by 401
Wan, F., Hong, L., Xiao, A., Jiang, T., & Zeng, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty543 · Cited by 381 · cited 1×
“…summarized the different studies that predict DTIs using various techniques covering structure-based, similarity-based, network-based, and AI/ML-based methods as presented in Liu Y. et al. (2016), Ezzat et al. (2017, 2018, 2019), Rayhan et al. (2017), Trosset and Cavé (2019), and Wan et al. (2019).”
MethodAin, Q. U., Aleksandrova, A., Roessler, F. D., & Ballester, P. J. (2015) · WIREs Computational Molecular Science · doi:10.1002/wcms.1225 · Cited by 357
Binding MOAD (Mother Of All Databases)
Hu, L., Benson, M. L., Smith, R. D., Lerner, M. G., & Carlson, H. A. (2005) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20512 · Cited by 328 · cited 2×
“These datasets/data sources are: PDBbind (Wang et al., 2004, 2005), BindingDB (Chen et al., 2001; Liu et al., 2007; Gilson et al., 2016), BindingMOAD—(the Mother Of All Databases; Hu et al., 2005; Benson et al., 2007; Ahmed et al., 2015; Smith et al., 2019), CSAR (Smith et al., 2011; Dunbar et al., 2013), AffinDB (Block…”
BackgroundDrug Similarity Integration Through Attentive Multi-view Graph Auto-Encoders
Ma, T., Xiao, C., Zhou, J., & Wang, F. (2018) · Proceedings of the Twenty-Seventh International Joint Conference on Artificial Intelligence · doi:10.24963/ijcai.2018/483 · Cited by 220
How to Recognize and Workaround Pitfalls in QSAR Studies: A Critical Review
Scior, T., Medina-Franco, J. L., Do, Q.-T., Martinez-Mayorga, K., Yunes Rojas, J. A., & Bernard, P. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789578213 · Cited by 197
Cited by
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
Deep learning in drug discovery: an integrative review and future challenges
Askr, H., Elgeldawi, E., Aboul Ella, H., Elshaier, Y. A. M. M., Gomaa, M. M., & Hassanien, A. E. (2023) · Artificial Intelligence Review · doi:10.1007/s10462-022-10306-1 · Cited by 390
Thafar, M. A., Olayan, R. S., Ashoor, H., Albaradei, S., Bajic, V. B., Gao, X., Gojobori, T., & Essack, M. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00447-2 · Cited by 143
“Several comprehensive review articles summarized, analyzed, and compared the methods belonging to these categories [23–29].”
BackgroundSelf-citationAmorim, A. M. B., Piochi, L. F., Gaspar, A. T., Preto, A. J., Rosário-Ferreira, N., & Moreira, I. S. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00352 · Cited by 132
Deep learning allows genome-scale prediction of Michaelis constants from structural features
Kroll, A., Engqvist, M. K. M., Heckmann, D., & Lercher, M. J. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001402 · Cited by 132
“Multiple approaches for the prediction of drug–target binding affinities (DTBAs) have been developed (reviewed in [8]).”
Background
Metadata
- Authors
- Thafar, M., Raies, A. B., Albaradei, S., Essack, M., & Bajic, V. B.
- Venue
- Frontiers in Chemistry
- Publisher
- Frontiers Media SA
- Published
- 2019-11-20
- Volume
- 7
- Pages
- 782-782
- ISSN
- 2296-2646 (ISSN-L)
- OpenAlex
- W2989848927
- Cited by
- 144
- References
- 28
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.